Assessing Health System Preparedness For Masld In The Middle East And North Africa

Background and aims

Metabolic dysfunction-associated steatotic liver illness (MASLD) represents an escalating healthcare load crossed nan Middle East and North Africa (MENA) region; however, system-level preparedness remains mostly undefined. This study aimed to measure existing models of care, objective infrastructure, argumentation frameworks, and supplier perspectives crossed 17 MENA countries.

Methods

A cross-sectional, mixed-methods study was distributed to clinicians from MASLD-related specialties crossed nan region. A full of 130 experts (87.2% consequence rate) from academic, public, and backstage sectors successful 17 countries participated. The questionnaire addressed nationalist policies, diagnostic and therapeutic practices, referral pathways, multidisciplinary squad (MDT) integration, and patient/public engagement. Quantitative responses were analyzed descriptively, while qualitative inputs underwent thematic analysis.

Results

Only 35.4% of respondents confirmed nan beingness of nationalist objective guidelines for MASLD, and 73.1% reported nan absence of a nationalist strategy. Structured referral pathways were reported by 39.2% of participants, and only 31.5% believed nan existent exemplary adequately addresses MASLD. While 60% supported MDT approaches, implementation remained inconsistent. Limited entree to transient elastography was reported by 26.2% of providers. Public acquisition efforts were minimal: 22.3% reported nary disposable tools, and 87.7% indicated nan absence of patient-reported outcomes data. Nearly half (47.7%) cited mediocre diligent adherence, attributed to debased awareness, financial barriers, and deficiency of follow-up.

Conclusions

This study reveals important gaps successful MASLD attraction crossed nan MENA region, including constricted nationalist strategies, anemic line implementation, underutilized multidisciplinary collaboration, and fragmented referral systems. Despite these deficiencies, nan insights gathered from location experts item some systemic challenges and actionable opportunities for improvement. Advancing MASLD attraction successful nan region will require much than aesculapian interventions; it demands a paradigm displacement that strengthens wellness strategy capacity, fosters responsive argumentation development, and builds quality assets capabilities. The corporate voices of frontline clinicians bespeak a beardown readiness for strategy transformation. Their telephone to action underscores nan urgency of integrated nationalist strategies, patient-centered multidisciplinary care, expanded nationalist education, and robust wellness strategy preparedness. A displacement from reactive measures to proactive, system approaches is basal to guarantee timely diagnosis, semipermanent management, and equitable entree to attraction for MASLD patients crossed MENA.